Trevor L. Brasel, PhDTrevor L. Brasel, PhD
Assistant Professor, Department of Microbiology Immunology
Study Director, Regulated Studies, Institutional Office of Regulated Nonclinical Studies


Education: Postdoctoral Fellowship, 2005, Lovelace Respiratory Research Institute, Albuquerque and The Research Centre for Toxicology and Hygienic Regulation of Biopreparations, Serpukhov, Russia
PhD, 2004, Texas Tech University Health Sciences, Lubbock, TX
BS, 2000, Texas Tech University, Lubbock, TX

Overview: Medical countermeasure evaluation under the FDA Animal Rule; model development; assay validation; advancing regulatory science.

Research Interests

Dr. Brasel’s interests lie in the strategic planning and execution of preclinical studies that evaluate medical countermeasures (vaccines and therapeutics) toward FDA licensure. As a Study Director, he ensures that controls are implemented to meet regulations for data quality and integrity. Dr. Brasel is currently focused on the implementation of quality systems and regulatory processes in A/BSL-4 laboratories. To date, no vaccines or therapeutics have been approved for human use against BSL-4 agents (e.g., Ebola and Marburg viruses). Through collaborations with world experts (many of whom reside at UTMB) in parallel with independently led studies, Dr. Brasel’s ultimate goal is FDA approval of high profile medical countermeasures specific for biodefense-related and emerging diseases.

Recent Publications

Search PubMed Database for Publications

SciVal Publications Overview